1. Home
  2. BTAI vs PNBK Comparison

BTAI vs PNBK Comparison

Compare BTAI & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTAI
  • PNBK
  • Stock Information
  • Founded
  • BTAI 2017
  • PNBK 1999
  • Country
  • BTAI United States
  • PNBK United States
  • Employees
  • BTAI N/A
  • PNBK N/A
  • Industry
  • BTAI Biotechnology: Pharmaceutical Preparations
  • PNBK Major Banks
  • Sector
  • BTAI Health Care
  • PNBK Finance
  • Exchange
  • BTAI Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • BTAI 6.6M
  • PNBK 6.6M
  • IPO Year
  • BTAI 2018
  • PNBK N/A
  • Fundamental
  • Price
  • BTAI $2.13
  • PNBK $1.19
  • Analyst Decision
  • BTAI Buy
  • PNBK
  • Analyst Count
  • BTAI 4
  • PNBK 0
  • Target Price
  • BTAI $37.00
  • PNBK N/A
  • AVG Volume (30 Days)
  • BTAI 279.4K
  • PNBK 2.9M
  • Earning Date
  • BTAI 03-11-2025
  • PNBK 03-31-2025
  • Dividend Yield
  • BTAI N/A
  • PNBK N/A
  • EPS Growth
  • BTAI N/A
  • PNBK N/A
  • EPS
  • BTAI N/A
  • PNBK N/A
  • Revenue
  • BTAI $2,276,000.00
  • PNBK $27,300,000.00
  • Revenue This Year
  • BTAI $105.36
  • PNBK N/A
  • Revenue Next Year
  • BTAI $46.93
  • PNBK N/A
  • P/E Ratio
  • BTAI N/A
  • PNBK N/A
  • Revenue Growth
  • BTAI 83.25
  • PNBK 3.61
  • 52 Week Low
  • BTAI $2.10
  • PNBK $1.09
  • 52 Week High
  • BTAI $56.00
  • PNBK $4.05
  • Technical
  • Relative Strength Index (RSI)
  • BTAI 28.68
  • PNBK 38.01
  • Support Level
  • BTAI $2.18
  • PNBK $1.37
  • Resistance Level
  • BTAI $2.60
  • PNBK $2.47
  • Average True Range (ATR)
  • BTAI 0.44
  • PNBK 0.28
  • MACD
  • BTAI -0.08
  • PNBK -0.05
  • Stochastic Oscillator
  • BTAI 0.94
  • PNBK 7.25

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: